» Articles » PMID: 34492731

Evaluation of Intervention Strategy of Thalassemia for Couples of Childbearing Ages in Centre of Southern China

Overview
Journal J Clin Lab Anal
Publisher Wiley
Date 2021 Sep 7
PMID 34492731
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To describe the free intervention strategy of thalassemia for childbearing couples in Guangzhou.

Methods: Routine hematology examinations were conducted for 137,222 couples. Among them, 37,501 couples who had mean corpuscular volume (MCV) <82 fL or mean corpuscular hemoglobin <27 pg were elected for Hb analysis and the deletions of four common α-thalassemia mutation. Reverse dot blot for common nondeletional α-thalassemia and β-thalassemia was selectively used. Three thousand twenty-two couples randomly selected were offered all those tests as a control group. Sanger sequencing, multiplex ligation-dependent probe amplification and next-generation sequencing were used for rare thalassemia. High-risk couples were offered prenatal diagnosis at 10-13 weeks' gestation based on informed consent.

Results: The carrier rates of α-, β-, and αβ-thalassemia and δβ thalassemia/deletional HPFH were 7.7%, 3.02%, 0.5% and 0.059% respectively. Of them, 1.37% were identified as at-risk couples and 345 couples terminated the pregnancy. No severe α- and β-thalassemia births were observed. In the control group, two β- thalassemia carriers and one case with -α /αα were misdiagnosed, but all at-risk couples were found, and we could save 1,523,774 ¥ using our strategy. The cut-off points of 73.46 fL and 23.25 pg would be useful to find -α /α thalassemia.

Conclusion: The intervention strategy was cost-effective and offered reference in population thalassemia screening.

Citing Articles

Routine antenatal molecular testing for α-thalassemia at a tertiary referral hospital in China: ten years of experience.

Li D, Liang L, Meng D, He S Front Genet. 2024; 15:1416047.

PMID: 38894721 PMC: 11183328. DOI: 10.3389/fgene.2024.1416047.


Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.

Ont Health Technol Assess Ser. 2023; 23(4):1-398.

PMID: 37637488 PMC: 10453298.


Utilization of multiple genetic methods for prenatal diagnosis of rare thalassemia variants.

Jiang F, Zhou J, Zuo L, Tang X, Li J, Li F Front Genet. 2023; 14:1208102.

PMID: 37529778 PMC: 10387553. DOI: 10.3389/fgene.2023.1208102.


Evaluation of intervention strategy of thalassemia for couples of childbearing ages in Centre of Southern China.

Jiang F, Zuo L, Li J, Chen G, Tang X, Zhou J J Clin Lab Anal. 2021; 35(10):e23990.

PMID: 34492731 PMC: 8529143. DOI: 10.1002/jcla.23990.

References
1.
Charoenkwan P, Sirichotiyakul S, Chanprapaph P, Tongprasert F, Taweephol R, Sae-Tung R . Anemia and hydrops in a fetus with homozygous hemoglobin constant spring. J Pediatr Hematol Oncol. 2006; 28(12):827-30. DOI: 10.1097/01.mph.0000243662.56432.37. View

2.
Liao C, Mo Q, Li J, Li L, Huang Y, Hua L . Carrier screening for alpha- and beta-thalassemia in pregnancy: the results of an 11-year prospective program in Guangzhou Maternal and Neonatal hospital. Prenat Diagn. 2005; 25(2):163-71. DOI: 10.1002/pd.1079. View

3.
Lin M, Zhong T, Chen Y, Wang J, Wu J, Lin F . Molecular epidemiological characterization and health burden of thalassemia in Jiangxi Province, P. R. China. PLoS One. 2014; 9(7):e101505. PMC: 4084819. DOI: 10.1371/journal.pone.0101505. View

4.
Traeger-Synodinos J, Harteveld C . Preconception carrier screening and prenatal diagnosis in thalassemia and hemoglobinopathies: challenges and future perspectives. Expert Rev Mol Diagn. 2017; 17(3):281-291. DOI: 10.1080/14737159.2017.1285701. View

5.
Liao C, Zhou J, Xie X, Li D . Screening for Hb Constant Spring in the Guangdong Province, South China, using the Sebia capillary electrophoresis system. Hemoglobin. 2011; 35(1):87-90. DOI: 10.3109/03630269.2010.547430. View